EMA TO BECOME MORE DIRECTLY INVOLVED IN PHARMA RESEARCH
April 1st, 2013
THE EUROPEAN Medicines Agency (EMA) has detailed how it might become more involved in pharmaceutical research in future. It has released a detailed plan saying under what circumstances the agency should become involved in studies and how it should choose projects and avoid conflicts of interest.But clearly it wants to do more. The plan says: “Given the agency’s central role…to promote and protect…health, and support its business processes in the evaluation and supervision of medicines, it is essential for EMA to further evolve from a passive bystander to ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.